Regulus Therapeutics
RGLS
#8769
Rank
C$0.13 B
Marketcap
$2.06
Share price
-1.99%
Change (1 day)
6.65%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -C$47.38 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$40.89 Million a decrease over its 2022 earnings that were of -C$38.39 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$47.38 Million15.89%
2023 -C$40.89 Million6.51%
2022 -C$38.39 Million2.53%
2021 -C$37.44 Million93.59%
2020 -C$19.34 Million-15.41%
2019 -C$22.87 Million-64.46%
2018 -C$64.32 Million-33.26%
2017 -C$96.37 Million-13.98%
2016 -C$0.12 Billion44.77%
2015 -C$77.39 Million-1.63%
2014 -C$78.68 Million203.6%
2013 -C$25.92 Million8.65%
2012 -C$23.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$5.79 B-12,017.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$10.28 B-21,265.86%๐Ÿ‡ซ๐Ÿ‡ท France
C$1.82 B-3,854.11%๐Ÿ‡บ๐Ÿ‡ธ USA
C$13.05 B-26,963.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
-C$0.26 Billion 433.96%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.29 Billion 489.91%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$9.56 Billion 19,557.70%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.17 Billion 236.16%๐Ÿ‡บ๐Ÿ‡ธ USA